Alexander Hardy Biomarin Pharmaceutical Inc (BMRN) insider trading activity

Alexander Hardy is Chief Executive Officer of BIOMARIN PHARMACEUTICAL INC. Currently has a direct ownership of 159,388 shares of BMRN, which is worth approximately $8.72 Million. The most recent transaction as insider was on Dec 01, 2025, when has been sold 16,570 shares (Common Stock) at a price of $55.03 per share, resulting in proceeds of $911,847. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 159K

9.42% 3M change

18.81% 12M change

Total Value Held $8.72 Million

Alexander Hardy Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 01 2025	SELL Payment of exercise price or tax liability	$911,847 $55.03 p/Share	16,570 Reduced 9.42%	159,388 Common Stock
Apr 30 2025	BUY Grant, award, or other acquisition	$20,302 $54.14 p/Share	375 Added 0.21%	175,958 Common Stock
Mar 17 2025	BUY Grant, award, or other acquisition	-	44,360 Added 20.17%	175,583 Common Stock
Mar 14 2025	SELL Payment of exercise price or tax liability	$203,667 $69.44 p/Share	2,933 Reduced 2.19%	131,223 Common Stock
Nov 29 2024	SELL Payment of exercise price or tax liability	$943,898 $66.03 p/Share	14,295 Reduced 9.63%	134,156 Common Stock
Oct 31 2024	BUY Grant, award, or other acquisition	$16,803 $56.01 p/Share	300 Added 0.2%	148,451 Common Stock
Mar 15 2024	BUY Grant, award, or other acquisition	-	32,780 Added 18.12%	148,151 Common Stock

Dec 01 2023	BUY Grant, award, or other acquisition	-	115,371 Added 50.0%	115,371 Common Stock

Alexander Hardy

Chief Executive Officer

San Rafael, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMRN shares.

Notify only if

Value

Insider Trading

Get notified when an Biomarin Pharmaceutical Inc insider buys or sells BMRN shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOMARIN PHARMACEUTICAL INC

Track Activities on BMRN

Account